Controlled-Release Drug Delivery Technology Market Segmentation By Product Type (Metered Dose Inhalers, Injectables, Infusion Pumps, Drug Eluting Stents, Nasal Spray and Others); By Technology Type (Wurster Technique, Implants, Micro Encapsulation, Targeted Delivery and Others); By Application Type (Oral, Nasal, Topical, Implantable, Injectable Targeted Delivery and Others); By Release Mechanism and By End User - Global Demand Analysis & Opportunity Outlook 2028

Introduction to the Market

Controlled release drug delivery system is used to release the drug at a predetermined rate for a specific period to maintain therapeutic level in blood. The controlled release drug systems are created for the physicians and patients to feel control in their lives, and the active ingredients of the drugs tend to release at a pre specified time, increasing the efficiency of dose. There are three types of controlled release drugs including pulse release, extended release and delayed release drugs.

Market size and Forecast

The controlled release drug delivery system technology market is anticipated to record a notable CAGR of around 8% over the forecast period 2020-2028. The key factors driving the growth of this market include the low treatment cost, reduced drug toxicity along with the increased therapeutic efficacy. Moreover, these technologies provide various advantages over traditional delivery systems, such as, uniform drug level which stabilizes the medical condition, reduced dosage and less side effects, and is also a significant factor anticipated to fuel the growth of the controlled release drug delivery system technology market over the forecast period.

The technology type market is segmented into wurster technique, implants, targeted delivery, micro encapsulation and others. Based on these segments, the targeted delivery segment will account for the leading share in the market on the back of its improved absorption, low risk of side effects, increased safety and it offers preferred site of action. Moreover, large number of key players has a strong portfolio for the technology. These factors, in turn, are expected to augment the market growth over the forecast period.

Growth Drivers

Rise in the Population Globally

There is a significant rise in the population of old people and children. Most of the old population suffers from health related problems, such as, compromised physical and mental functions that affect the intake of their medications. In addition, the body of the children and old people cannot tolerate the side effects of the drugs and its high dosage. Hence, with rising population of patients and its various innovations, the market for controlled release drug delivery technology will witness a steep growth during the forecast period.

Advancements in the Drug Delivery Systems

The factor driving the controlled release drug delivery technology market is the rise in the spending of research & development to cure the non communicable diseases and diseases persisting for a long time, efficiently.  The systems are working to be mechanically strong in order to stabilize the medical condition of the patient along with the achievement of high drug loading. Moreover, the research and development is working on cost effective controlled release drug delivery technology, which is estimated to increase the notable rate of its adoption over the forecast period.

Restraints

High Cost of Controlled Release Drug Delivery Technology and Non-Biocompatibility of Materials Used

Despite of the advantages related to the controlled release drug delivery technology, high cost of the system and non biocompatibility & biodegradability with appropriate controlled release properties of the material used in drugs is expected to act as a key restraint to the growth of controlled release drug delivery technology market. Further, the inactive substances that act as a medium for a drug are deemed acceptable for the therapy of children are very few and the need for high dose of API (Active Pharmaceutical Ingredient) is hampering the growth of the market.

Market Segmentation

Our in depth analysis of controlled release drug delivery technology market include the following segments:

By Product Type

• Metered Dose Inhalers
• Injectables
• Nasal Sprays
• Infusion Pumps
• Drug Eluting Stents
• Others

By Technology Type

• Wurster Technique
• Implants
• Micro Encapsulation
• Targeted Delivery
• Others

By Application Type

• Oral
• Nasal
• Topical
• Implantable
• Injectable Targeted Delivery
• Others

By Release Mechanism

• Polymer Based Systems
• Activation Modulated 
  • Osmotic Pressure Activated
  • Mechanically Activated
  • Vapour Pressure Activated
• Micro Reservoir Partition
• Chemically Activated 
  • Ph Activated
  • Enzyme Activated

By End User

• Hospitals
• Research Centres
• Government & Private Laboratories
• Personal Use
• Pharmaceutical Manufacturers
• Others

By Region

On the basis of regional analysis, the controlled release drug delivery technology market is segmented into five major region including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market for Enterprise file sync and sharing platform in North America is anticipated to hold the largest share on the account of prevailing diseases related to gastrointestinal disorders, advancement in the technological infrastructure of pharmaceutical industry along with the increasing activities of research & development. The increase in the number of gastrointestinal patients will result in the rise in demand for controlled release drug delivery technology. The Asia Pacific market is predicted to be rapidly growing on the back of increase in geriatric and paediatric population in the region, rising demand for the controlled release drugs dosage over the forecast period.

The controlled release drug delivery technology market is further classified on the basis of region as follows:

• North America (US and Canada) Market size, Y-O-Y growth and Opportunity analysis.
• Europe (France, Germany, Italy, Spain, UK, Netherland, Switzerland, Belgium and Other parts of Europe) Market size, Y-O-Y growth and Opportunity analysis.
• Asia Pacific (Japan, India, China, Thailand, Indonesia, South Korea, Singapore and Vietnam) Market size, Y-O-Y growth and Opportunity analysis.
• Latin America (Brazil, Colombia, Chile and Argentina) Market size, Y-O-Y growth and Opportunity analysis.
• Middle East & Africa (Saudi Arabia, South Africa, United Arab Emirates, Israel and Kuwait) Market size, Y-O-Y growth and Opportunity analysis.

Top Featured Companies Dominating The Market

• Pfizer Inc. 
  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis
• Mayne Pharma
• AstraZeneca Plc
• Insulet Corporation
• Becton Dickinson and Co
• Bespak
• West Pharmaceutical Services
• Enable Injections Inc
• Biogen Inc.